ATTR Amyloidosis Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting attr amyloidosis clinical trials across 19 countries. Studies span Phase 1, Phase 2, Phase 3. Top locations include Madrid, Spain, Barcelona, Spain, Berlin, Germany. Updated daily from ClinicalTrials.gov.


ATTR Amyloidosis Trials at a Glance

12 actively recruiting trials for attr amyloidosis are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Madrid, Barcelona, and Berlin. Lead sponsors running attr amyloidosis studies include AstraZeneca, Columbia University, and Alnylam Pharmaceuticals.

Browse attr amyloidosis trials by phase

About ATTR Amyloidosis Clinical Trials

Looking for clinical trials for ATTR Amyloidosis? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ATTR Amyloidosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ATTR Amyloidosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

ATTR Amyloidosis
AstraZeneca52,121 enrolled26 locationsNCT06355934
Recruiting

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type
Paolo Milani200 enrolled1 locationNCT06251778
Recruiting

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Transthyretin-Mediated AmyloidosisATTR Amyloidosis
Alnylam Pharmaceuticals1,500 enrolled40 locationsNCT04561518
Recruiting

The Italian Transthyretin Amyloidosis Web-Network

ATTR Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia1,000 enrolled30 locationsNCT05444920
Recruiting

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

Amyloidosis CardiacAmyloidosis, HereditaryWild-type ATTR Amyloidosis+1 more
University of Sao Paulo General Hospital70 enrolled1 locationNCT07314268
Recruiting
Phase 3

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

AL AmyloidosisCardiac AmyloidosisATTR Amyloidosis
Life Molecular Imaging GmbH200 enrolled14 locationsNCT05184088
Recruiting

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

Cardiac AmyloidosisCardiomyopathy, HypertrophicLumbar Spinal Stenosis+3 more
Columbia University1,663 enrolled6 locationsNCT06034405
Recruiting

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

Multifocal motor neuropathyPolyneuropathiesPOEMS Syndrome+6 more
Rigshospitalet, Denmark520 enrolled1 locationNCT06040567
Recruiting

A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.

Tricuspid RegurgitationMitral RegurgitationATTR-CM+2 more
Medical University of Vienna600 enrolled8 locationsNCT06836011
Recruiting

ATTR Cardiac Amyloidosis in a Selected Population

carpal tunnel syndromeCardiac AmyloidosisATTR Amyloidosis Wild Type+1 more
Helse Møre og Romsdal HF180 enrolled1 locationNCT06458374
Recruiting
Phase 1Phase 2

Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

ATTR Amyloidosis Wild Type
Steen Hvitfeldt Poulsen35 enrolled1 locationNCT06318260
Recruiting

Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)

ATTR AmyloidosisCardiopathy
Institut Mutualiste Montsouris150 enrolled1 locationNCT06367842